SOD1 miRNA therapy(Biogen)

N/A

Report date: 2024/10/24 16:49:20

NME

Base Information

Drug NameSOD1 miRNA therapy(Biogen)

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA

Mechanisms of ActionSuperoxide dismutase inhibitors

TargetsSuperoxide dismutase

Therapy Area/IndicationsAmyotrophic Lateral Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBiogen Inc

China Registration ClassN/A

Active CompaniesBiogen Inc

Inactive CompaniesN/A

Active IndicationsAmyotrophic Lateral Sclerosis

Inactive IndicationsN/A

ATC CodeN/A